Zydus Cadila’s JV receives EIR Report for manufacturing facility at Ahmedabad

12 Jul 2018 Evaluate

Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group)’s 50: 50 joint venture company--Zydus Hospira Oncology has received an Establishment Inspection Report (EIR) for manufacturing facility situated at Ahmedabad,  from  the US Food and Drug Administration (USFDA) which concluded that the inspection is closed and States that the inspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from April 5-12, 2018.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×